Guselkumab-mediated marked improvement in a case of refractory ulcerative colitis resistant to mirikizumab: evidence for switching between IL-23p19 inhibitors
J Crohns Colitis
.
2026 Jan 9;20(1):jjaf230.
doi: 10.1093/ecco-jcc/jjaf230.
Authors
Reiko Kunisaki
1
2
,
Hideaki Kimura
1
,
Shin Maeda
2
Affiliations
1
Inflammatory Bowel Disease Centre, Yokohama City University Medical Centre, Yokohama, 232-0024, Japan.
2
Department of Gastroenterology, Graduate School of Medicine, Yokohama City University, Yokohama, 236-004, Japan.
PMID:
41397905
DOI:
10.1093/ecco-jcc/jjaf230
No abstract available